BackTRACON Pharmaceuticals Overview

TRACON Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for TCON.

Quarterly EBIT

-$2.91M
↓ 270.01% YoY

As of Jun 30, 2024

Annual EBIT (TTM)

-$7.31M
↑ 64.01% YoY

Trailing 12 months ending Jun 30, 2024

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin